Patient preferences on rheumatoid arthritis second-line treatment: a discrete choice experiment of Swedish patients.

Respondents found either effectiveness, route of administration or severe side effects as the most important attribute. Patients noting effectiveness as most important were more willing than other patients to accept higher risks of side effects.